1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
;
Arildsen, Nicolai Skovbjerg
LU
;
Hartman, Linda
LU
;
Malander, Susanne
LU
;
Kannisto, Päivi
LU
;
Måsbäck, Anna
LU
and
Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv : an international journal of pathology
Mark
- 2019
-
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
Arildsen, Nicolai Skovbjerg LU ; Martin de la Fuente, Laura LU ; Måsbäck, Anna LU ; Malander, Susanne LU ; Forslund, Ola LU ; Kannisto, Päivi LU and Hedenfalk, Ingrid LU
(2019)
In Scientific Reports
9(1).
p.1-8
Mark
- Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
-
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
Huttenhain, Ruth ; Choi, Meena ; Martin de la Fuente, Laura LU ; Oehl, Kathrin ; Chang, Ching-Yun ; Zimmermann, Anne-Kathrin ; Malander, Susanne LU ; Olsson, Hakan LU
;
Surinova, Silvia
and
Clough, Timothy
, et al.
(2019)
In Molecular and Cellular Proteomics
18(9).
p.1836-1850
Mark
- Pattern of endocrine treatment for epithelial ovarian cancer in the Southeast medical region of Sweden : a population-based study
- 2018
- Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
-
Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
Martín De La Fuente, Laura LU ; Malander, Susanne LU ; Hartman, Linda LU ; Jönsson, Jenny Maria LU ; Ebbesson, Anna LU ; Nilbert, Mef LU ; Måsbäck, Anna LU and Hedenfalk, Ingrid LU
(2018)
In International Journal of Gynecological Pathology
37(2).
p.101-109
Mark
- Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
- Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA) : results from a double-blind, phase 3, randomised controlled trial
- 2017
-
Involvement of chromatin remodeling genes and the Rho GTPases RhoB and CDC42 in ovarian clear cell carcinoma
Arildsen, Nicolai Skovbjerg LU ; Jönsson, Jenny Maria LU ; Bartuma, Katarina LU ; Ebbesson, Anna LU ; Westbom-Fremer, Sofia ; Måsbäck, Anna LU ; Malander, Susanne LU ; Nilbert, Mef LU and Hedenfalk, Ingrid A. LU
(2017)
In Frontiers in Oncology
7(MAY).
p.1-11
Mark